Click Here to return To Results

 

The SANAD II study of the Effectiveness and Cost-Effectiveness of Levetiracetam, Zonisamide, or Lamotrigine for Newly Diagnosed Focal Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial Lancet 397:1363-1374, Marson, A.,et al, 2021 See this aricle in Pubmed Article Abstract These findings do not support the use of levetiracetam or zonisamide as first-line treatments for patients with focal epilepsy. Lamotrigine should remain a first-line treatment for patients with focal epilepsy and should be the standard treatment in future trials.

Related Tags

(click to filter results - removes previous filter) anticonvulsants anticonvulsants,effectiveness anticonvulsants,selection of efficacy lamotrigine levetiracetam review article seizure seizure,focal seizure,treatment of

Click Here to return To Results